JPS6148487B2 - - Google Patents
Info
- Publication number
- JPS6148487B2 JPS6148487B2 JP54022397A JP2239779A JPS6148487B2 JP S6148487 B2 JPS6148487 B2 JP S6148487B2 JP 54022397 A JP54022397 A JP 54022397A JP 2239779 A JP2239779 A JP 2239779A JP S6148487 B2 JPS6148487 B2 JP S6148487B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- methyl
- reaction
- hydroxyl group
- grignard
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
【発明の詳細な説明】
本発明は補酵素QおよびビタミンKの製造中間
体として有用な新規なハイドロキノン誘導体に関
する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel hydroquinone derivative useful as an intermediate for the production of coenzyme Q and vitamin K.
2・3−ジメトキシ−5−メチル−1・4−ハ
イドロキノンおよび2−メチル−1・4−ナフト
ハイドロキノンの如き母核に対するポリプレニル
鎖の導入は、補酵素QおよびビタミンKの製造に
おける主要工程の一つであり、従来種々の方法が
提案されている。グリニヤール反応を応用して側
鎖を母核に導入する方法は公知であり〔例えばJ.
Am.Chem.Soc.96、8046(1974)、特開昭52−
65236〕、これにより比較的高い反応収率が得られ
る。概略すればこの方法は臭素化された母核に金
属マグネシウムを作用させてグリニヤール試薬を
調製し、次いで側鎖成分のポリプレニルハライド
例えばデカプレニルブロマイド、フイチルブロマ
イド、ゲラニルゲラニルブロマイド等とカツプリ
ングさせることよりなる。この場合、母核上の遊
離の状態の水酸基は、グリニヤール試薬の調製な
らびにカツプリング反応の支障となるので、該水
酸基の水素原子を他の基で置換することによつ
て、水酸基をあらかじめ保護する必要がある。 The introduction of polyprenyl chains into the core, such as 2,3-dimethoxy-5-methyl-1,4-hydroquinone and 2-methyl-1,4-naphthohydroquinone, is one of the main steps in the production of coenzyme Q and vitamin K. Various methods have been proposed in the past. A method of introducing a side chain into a mother nucleus by applying the Grignard reaction is known [for example, J.
Am.Chem.Soc. 96 , 8046 (1974), JP-A-1972-
65236], which results in relatively high reaction yields. Briefly, this method involves preparing a Grignard reagent by reacting metallic magnesium with a brominated mother nucleus, and then coupling it with a side chain component of polyprenyl halide such as decaprenyl bromide, phytyl bromide, geranylgeranyl bromide, etc. Become. In this case, the free hydroxyl group on the mother nucleus interferes with the preparation of the Grignard reagent and the coupling reaction, so it is necessary to protect the hydroxyl group in advance by replacing the hydrogen atom of the hydroxyl group with another group. There is.
上記の水素原子の置換基としては、補酵素Qの
母核に関してアセチル基、メトキシメチル基、エ
トキシエチル基、テトラヒドロピラニル基等が知
られている〔例えば特公昭50−7063号、同50−
39655号、特開昭52−65236号参照〕。またビタミ
ンKの母核に関してはアセチル基、メチル基、ベ
ンジル基、メトキシメチル基、テトラヒドロピラ
ニル基、トリアルキルシリル基等が公知である
〔例えば特公昭42−14628号、同44−28297号、同
50−29468号、同50−39655号、J.Am.Chem.Soc.
96、8046(1974)参照〕。水酸基の保護基はグリ
ニヤール反応の高い収率をもたらすものであると
ともに、グリニヤール試薬の調製を容易とし、反
応中安定であり、かつグリニヤール反応後の所望
の段階で脱離しうるものであることが望まれる。
この意味で前記の置換基はグリニヤール反応にお
ける水酸基の保護基として全く適さないか、ある
いは保護基としての作用が実用上満足でない。た
とえばメチル基で置換された水酸基すなわちメト
キシ基は、酸および塩基に対して安定であるが、
グリニヤール反応後メチル基を脱離して水酸基に
戻すことが極めて困難である。アセチル基は、そ
れによつて水酸基の水素原子が置換された母核か
ら、対応するグリニヤール試薬を調製することが
できないので、保護基として全く不適当である。
トリメチルハイドロキノンの水酸基をベンジル基
で保護する場合はグリニヤール反応が生じないこ
と〔J.Am.Chem.Soc.、64、440(1942)〕から、
2・3−ジメトキシ−5−メチル−1・4−ハイ
ドロキノンおよび2−メチル−1・4−ナフトハ
イドロキノンに関しても、水酸基をベンジル基で
保護した場合はグリニヤール反応が生じないこと
が推測される。トリアルキルシリル基では、グリ
ニヤール反応中水酸基を保護し続けることができ
ない。テトラヒドロピラニル基で保護した水酸基
は酸に対して不安定であるため、母核を注意して
取扱わねばならず、反応条件に制限を受ける。さ
らにメトキシメチル基も、それにより保護された
水酸基が酸に対して不安定であるので、母核をグ
リニヤール反応に先立つて注意深く精製すること
を要するほか、グリニヤール試薬とポリプレニル
ハライドとのカツプリング反応の収率も満足しう
るほど高くない。 As substituents for the hydrogen atom mentioned above, acetyl group, methoxymethyl group, ethoxyethyl group, tetrahydropyranyl group, etc. are known for the mother nucleus of coenzyme Q [for example, Japanese Patent Publication No. 7063/1986,
39655, JP-A No. 52-65236]. Furthermore, regarding the mother nucleus of vitamin K, acetyl group, methyl group, benzyl group, methoxymethyl group, tetrahydropyranyl group, trialkylsilyl group, etc. are known [for example, Japanese Patent Publication No. 14628/1986, Japanese Patent Publication No. 44-28297, same
No. 50-29468, No. 50-39655, J.Am.Chem.Soc.
96 , 8046 (1974)]. It is desirable that the protecting group for the hydroxyl group is one that brings about a high yield in the Grignard reaction, facilitates the preparation of the Grignard reagent, is stable during the reaction, and can be eliminated at a desired stage after the Grignard reaction. It can be done.
In this sense, the above-mentioned substituents are either not suitable at all as a protecting group for a hydroxyl group in the Grignard reaction, or their action as a protecting group is not satisfactory in practice. For example, hydroxyl or methoxy groups substituted with methyl groups are stable to acids and bases;
After the Grignard reaction, it is extremely difficult to remove the methyl group and return it to a hydroxyl group. The acetyl group is completely unsuitable as a protecting group, since the corresponding Grignard reagent cannot be prepared from the nucleus by which the hydrogen atom of the hydroxyl group has been replaced.
Since the Grignard reaction does not occur when the hydroxyl group of trimethylhydroquinone is protected with a benzyl group [J.Am.Chem.Soc., 64 , 440 (1942)],
Regarding 2,3-dimethoxy-5-methyl-1,4-hydroquinone and 2-methyl-1,4-naphthohydroquinone, it is presumed that the Grignard reaction does not occur when the hydroxyl group is protected with a benzyl group. Trialkylsilyl groups cannot continue to protect the hydroxyl group during the Grignard reaction. Since the hydroxyl group protected by the tetrahydropyranyl group is unstable to acids, the mother nucleus must be handled with care, and the reaction conditions are limited. Furthermore, since the hydroxyl group protected by the methoxymethyl group is unstable to acids, the mother nucleus must be carefully purified prior to the Grignard reaction, and the coupling reaction between the Grignard reagent and polyprenyl halide requires careful purification of the mother nucleus prior to the Grignard reaction. The yield is also not satisfactorily high.
本発明はグリニヤール反応によりポリプレニル
鎖を母核に導入する工程を含む補酵素Qおよびビ
タミンKの製造法において有利に使用されるハイ
ドロキノン母核すなわち水酸基の保護された上述
の如き問題を有しない下記式()で示されるハ
イドロキノン誘導体を提供するものである。 The present invention is directed to the hydroquinone core, which is advantageously used in a process for producing coenzyme Q and vitamin K, which includes the step of introducing a polyprenyl chain into the core by Grignard reaction, that is, the following formula which does not have the above-mentioned problems and has a protected hydroxyl group. The present invention provides a hydroquinone derivative represented by ().
〔式()中R1およびR2はCH3O基を表わすか、
または連結して−CH=CH−CH=CH−基を表わ
す〕
式()で示される本発明のハイドロキノン誘
導体は、自体公知の方法に従い、遊離水酸基を有
する対応ハイドロキノン誘導体()にメトキシ
エトキシメチルハライド()を反応させること
により製造することができる〔Tetrahedron
Letters(11)809(1976)〕。 [In formula (), R 1 and R 2 represent a CH 3 O group,
or linked to represent a -CH=CH-CH=CH- group] The hydroquinone derivative of the present invention represented by the formula () can be obtained by adding methoxyethoxymethyl halide to the corresponding hydroquinone derivative () having a free hydroxyl group according to a method known per se. () can be produced by reacting [Tetrahedron
Letters (11) 809 (1976)].
〔式中R1およびR2は前記定義であり、Xはハロゲ
ン原子である〕
式()の化合物は酸および塩基に対して安定
であるので、原料化合物()または()に由
来する不純物を除去するための精製処理を適用し
なくとも、グリニヤール試薬の調製およびポリプ
レニルハライドとのカツプリング反応を行なうこ
とができ、しかも反応収率は高い。また、本発明
による保護基はカツプリング反応後触媒量の臭化
水素酸もしくは塩酸の存在下エタノール中で加熱
することにより、容易に脱離させることができる
ので、本発明のハイドロキノン誘導体は補酵素Q
およびビタミンKの製造中間体として極めて有用
である。 [In the formula, R 1 and R 2 are as defined above, and X is a halogen atom] Since the compound of formula () is stable against acids and bases, impurities derived from the raw material compound () or () can be avoided. The Grignard reagent can be prepared and the coupling reaction with polyprenyl halide can be carried out without applying purification treatment for removal, and the reaction yield is high. In addition, the protecting group according to the present invention can be easily removed by heating in ethanol in the presence of a catalytic amount of hydrobromic acid or hydrochloric acid after the coupling reaction.
It is also extremely useful as an intermediate for the production of vitamin K.
次に実施例により本発明を具体的に説明する。 Next, the present invention will be specifically explained with reference to Examples.
実施例 1
(1) 2・3−ジメトキシ−5−メチル−6−ブロ
ムハイドロキノン
クロロホルム500mlに2・3−ジメトキシ−
5−メチルハイドロキノン46.0gを溶解した溶
液に臭素39.5gのクロロホルム70ml中溶液を窒
素雰囲気下5℃にて滴下した。同温度で3時間
撹拌後、洗浄水の着色がみられなくなるまで反
応液を水洗した。次いで硫酸マグネシウムで乾
燥し、溶媒を減圧留去して2・3−ジメトキシ
−5−メチル−6−ブロムハイドロキノン65.5
gを得た。Example 1 (1) 2,3-dimethoxy-5-methyl-6-bromohydroquinone 2,3-dimethoxy-5-methyl-6-bromohydroquinone in 500 ml of chloroform
A solution of 39.5 g of bromine in 70 ml of chloroform was added dropwise to a solution of 46.0 g of 5-methylhydroquinone at 5° C. under a nitrogen atmosphere. After stirring at the same temperature for 3 hours, the reaction solution was washed with water until no color was observed in the washing water. It was then dried over magnesium sulfate, and the solvent was distilled off under reduced pressure to give 2,3-dimethoxy-5-methyl-6-bromohydroquinone 65.5
I got g.
(2) メトキシエトキシメチルクロライド
メチルセロソルブ152gとS−トリオキサン
66gの混合液を氷冷し、透明な溶液となるまで
塩化水素ガスを吹き込んだのちペンタンで抽出
した。ペンタン溶液を硫酸マグネシウムで乾燥
したのち溶媒を減圧下に留去し、さらに減圧蒸
留して、メトキシエトキシメチルクロライド
(沸点82℃/75mmHg)を得た。なおこの合成は
Tetrahedron Letters(11)809(1976)に記載の
方法に準拠して行なつたものである。(2) Methoxyethoxymethyl chloride 152g methyl cellosolve and S-trioxane
66 g of the mixture was cooled on ice, hydrogen chloride gas was blown into the solution until it became a clear solution, and then extracted with pentane. After drying the pentane solution over magnesium sulfate, the solvent was distilled off under reduced pressure, and further distillation was performed under reduced pressure to obtain methoxyethoxymethyl chloride (boiling point: 82°C/75mmHg). Note that this synthesis
This was carried out in accordance with the method described in Tetrahedron Letters (11) 809 (1976).
(3) 2・3−ジメトキシ−5−メチル−6−ブロ
ムハイドロキノン−1・4−ジメトキシエトキ
シメチルエーテル
2・3−ジメトキシ−5−メチル−6−ブロ
ムハイドロキノン62.5gをジメチルホルムアミ
ド880mlに溶解した溶液を−30℃に冷却し、こ
れに50%水素化ナトリウム22.9gを少量ずつ添
加した。添加後同温度で1時間撹拌したのちさ
らにメトキシエトキシメチルクロライド65gを
−30℃で滴下した。滴下後室温で3時間撹拌
し、次いで50mlのエタノールを加えて1時間撹
拌したのち、反応後を氷水に注ぎ、イソプロピ
ルエーテルで抽出した。有機層を硫酸マグネシ
ウムで乾燥後溶媒を減圧留去することにより
2・3−ジメトキシ−5−メチル−6−ブロム
ハイドロキノン−1・4−ジメトキシエトキシ
メチルエーテル91.5gを得た。収率88%。生成
物の確認データは次のとおり。(3) 2,3-dimethoxy-5-methyl-6-bromohydroquinone-1,4-dimethoxyethoxymethyl ether A solution of 62.5 g of 2,3-dimethoxy-5-methyl-6-bromohydroquinone dissolved in 880 ml of dimethylformamide. was cooled to -30°C, and 22.9 g of 50% sodium hydride was added little by little. After the addition, the mixture was stirred at the same temperature for 1 hour, and then 65 g of methoxyethoxymethyl chloride was added dropwise at -30°C. After the dropwise addition, the mixture was stirred at room temperature for 3 hours, then 50 ml of ethanol was added and stirred for 1 hour. The reaction mixture was poured into ice water and extracted with isopropyl ether. After drying the organic layer over magnesium sulfate, the solvent was distilled off under reduced pressure to obtain 91.5 g of 2,3-dimethoxy-5-methyl-6-bromohydroquinone-1,4-dimethoxyethoxymethyl ether. Yield 88%. Confirmation data for the product is as follows.
赤外線吸収スペクトル(neat)
2930、2875、1458、1410、1386、1340、1238、
1166、1115、1078、966cm-1
核磁気共鳴スペクトル(CDCl3)
δ=5.12(d、4H)、4.05−3.78(m、4H)、
3.80(s、6H)、3.60−3.43(m、4H)、
3.33(s、6H)、2.27(s、3H)
実施例 2
J.Am.Chem.Soc.、63、528(1941)に記載さ
れた方法に従つて2−メチル−1・4−ナフトキ
ノンの臭素化および塩化第一錫による臭素化物の
還元により調製した2−メチル−3−ブロムナフ
トハイドロキノン57.8g、50%水素化ナトリウム
22gおよびメトキシエトキシメチルクロライド
62.5gを用いて、実施例1と同様の方法で反応を
行なつたのち、反応混合物を氷水に注いで固体を
析出させた。これを別してヘキサンで再結晶す
ることにより、2−メチル−3−ブロムナフトハ
イドロキノン−1・4−ジメトキシエトキシメチ
ルエーテル92.3gが得られた。収率94%。生成物
の確認データは次のとおり。融点51〜53.8℃。Infrared absorption spectrum (neat) 2930, 2875, 1458, 1410, 1386, 1340, 1238,
1166, 1115, 1078, 966 cm -1 nuclear magnetic resonance spectrum (CDCl 3 ) δ = 5.12 (d, 4H), 4.05-3.78 (m, 4H),
3.80 (s, 6H), 3.60-3.43 (m, 4H),
3.33 (s, 6H), 2.27 (s, 3H) Example 2 Bromine of 2-methyl-1,4-naphthoquinone according to the method described in J.Am.Chem.Soc., 63 , 528 (1941) 57.8 g of 2-methyl-3-bromonaphthohydroquinone prepared by oxidation and reduction of the bromide with stannous chloride, 50% sodium hydride.
22g and methoxyethoxymethyl chloride
After carrying out a reaction in the same manner as in Example 1 using 62.5 g, the reaction mixture was poured into ice water to precipitate a solid. This was separated and recrystallized from hexane to obtain 92.3 g of 2-methyl-3-bromnaphthohydroquinone-1,4-dimethoxyethoxymethyl ether. Yield 94%. Confirmation data for the product is as follows. Melting point 51-53.8℃.
赤外線吸収スペクトル(KBr)
2915、2885、1580、1470、1450、1368、1350、
1236、1170、1105、965、925cm-1
核磁気共鳴スペクトル(CDCl3)
δ=8.20−7.90(m、2H)、7.55−7.36(m、
2H)、5.18(d、4H)、4.08−3.85(m、
4H)、3.62−3.45(m、4H)、3.33(s、
6H)、2.48(s、3H)Infrared absorption spectrum (KBr) 2915, 2885, 1580, 1470, 1450, 1368, 1350,
1236, 1170, 1105, 965, 925 cm -1 Nuclear magnetic resonance spectrum (CDCl 3 ) δ = 8.20-7.90 (m, 2H), 7.55-7.36 (m,
2H), 5.18 (d, 4H), 4.08−3.85 (m,
4H), 3.62-3.45 (m, 4H), 3.33 (s,
6H), 2.48(s, 3H)
Claims (1)
または連結して−CH=CH−CH=CH−基を表わ
す〕 で示されるハイドロキノン誘導体。[Claims] 1 General formula () [In formula (), R 1 and R 2 represent a CH 3 O group,
or linked to represent a -CH=CH-CH=CH- group] A hydroquinone derivative represented by the following.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2239779A JPS55113733A (en) | 1979-02-26 | 1979-02-26 | Derivative of hydroquinone |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2239779A JPS55113733A (en) | 1979-02-26 | 1979-02-26 | Derivative of hydroquinone |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS55113733A JPS55113733A (en) | 1980-09-02 |
| JPS6148487B2 true JPS6148487B2 (en) | 1986-10-24 |
Family
ID=12081521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2239779A Granted JPS55113733A (en) | 1979-02-26 | 1979-02-26 | Derivative of hydroquinone |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS55113733A (en) |
-
1979
- 1979-02-26 JP JP2239779A patent/JPS55113733A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS55113733A (en) | 1980-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS6113449B2 (en) | ||
| US4270003A (en) | Hydroquinone derivatives and preparation thereof | |
| JPS6148487B2 (en) | ||
| AU729548B2 (en) | Process for the preparation of substituted anthraquinones and application to the preparation of rheins | |
| KR0170778B1 (en) | Improved Manufacturing Method of Ketone Compounds | |
| JPS5879943A (en) | Manufacture of vitamin k3 and k4 and derivatives | |
| JPS5938945B2 (en) | Method for producing hydroquinone derivatives | |
| JPS60237039A (en) | Benzalacetophenone, its derivative and their production | |
| JP3010264B2 (en) | Method for producing isocoumarins | |
| JPS601292B2 (en) | Synthesis method of dihydrocoenzyme Q compounds | |
| JPS6011896B2 (en) | Method for producing quinone derivatives | |
| JPS6219427B2 (en) | ||
| JP2860676B2 (en) | Method for producing 1-isoquinolines | |
| JP2890155B2 (en) | Method for producing diphenylmethane derivative | |
| JPS63239238A (en) | Manufacture of optically active carbonyl compound | |
| US2471090A (en) | 3-thenyl bromide salts | |
| CN121135564A (en) | A method for synthesizing ethynylbenzocycloalkyl alcohol derivatives | |
| JPH02231453A (en) | Aryl group-substituted diphenol monoester, and preparation thereof | |
| CN119019271A (en) | A kind of synthesis method of free racemic salbutamol | |
| JPH0662470B2 (en) | Process for producing optically active hexa-2,4-diyne-1,6-diols | |
| JP2007008886A (en) | Method for producing isoprenoid derivative | |
| JPS6259688B2 (en) | ||
| JP2002226430A (en) | Method for producing aromatic carboxylate having substituent | |
| JPS6330449A (en) | Production of 2-cyclopentenone derivative | |
| JPH0710783A (en) | New acetylene system derivative |